Unknown

Dataset Information

Emerging systemic treatment options in meningioma.


ABSTRACT:

Purpose

Meningiomas are the most frequently diagnosed intracranial neoplasms. Usually, they are treated by surgical resection in curative intent. Radiotherapy and stereotactic radiosurgery are commonly applied in the adjuvant setting in newly diagnosed atypical (CNS WHO grade 2), and anaplastic (CNS WHO grade 3) meningioma, especially if gross total resection is not feasible, and in recurrent cases. Conversely, the evidence for pharmacotherapy in meningioma is scarce.

Methods

The available literature of systemic treatment in meningioma was screened using PubMed, and ongoing clinical trials were explored using ClinicalTrials.gov.

Results

Classical cytotoxic agents, somatostatin analogs, and antihormone treatments have shown only limited efficacy. In contrast, tyrosine

SUBMITTER: Mair MJ 

PROVIDER: S-EPMC9989003 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature